openPR Logo
Press release

Global Prostate Cancer Diagnostics Market is valued at 10000 million US$ in 2018 and will reach 17600 million US$ by the end of 2025, growing at a CAGR of 7.3% | Valuates Reports

06-01-2019 07:56 AM CET | Health & Medicine

Press release from: Valuates Reports

Global Prostate Cancer Diagnostics Market is valued at 10000

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

This report studies the global market size of Prostate Cancer Diagnostics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prostate Cancer Diagnostics in these regions.

This research report categorizes the global Prostate Cancer Diagnostics market by top players/brands, region, type and end user. This report also studies the global Prostate Cancer Diagnostics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Read More https://reports.valuates.com/sreport/QYRE-Auto-23M44/Global_Prostate_Cancer_Diagnostics_Market

Market Trends:

The classification of Prostate Cancer Diagnostics includes Tumor Biomarker Tests, Imaging, Biopsy and other, and most of Prostate Cancer Diagnostics use the method of Biopsy, the proportion of Biopsy in 2017 is about 44.65%. Prostate Cancer Diagnostics is widely used for the people with Prostate Cancer, The most proportion of Prostate Cancer Diagnostics is used for people with the age between 55 and 75, and the proportion is about 70.24% in 2017. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49.84% in 2017. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28% in 2017.

The study objectives of this report are:
To study and analyze the global Prostate Cancer Diagnostics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Prostate Cancer Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Prostate Cancer Diagnostics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Prostate Cancer Diagnostics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Get Sample Copy Of This Report https://reports.valuates.com/request/sample/QYRE-Auto-23M44/Global_Prostate_Cancer_Diagnostics_Market


The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
BioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

Market size by Product
Tumor Biomarker Tests
Imaging
Biopsy
Other
Market size by End User
age < 55
age 55-75
age > 75

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa


This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Prostate Cancer Diagnostics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

Avail Discount On This Report : https://reports.valuates.com/request/discount/QYRE-Auto-23M44/Global_Prostate_Cancer_Diagnostics_Market

About Valuates Reports :
Our aim is to collate unparalleled Market insights and notify our customers as and when it happens.

Valuates is curating premium Market Research Reports from the leading publishers around the globe. We will help you map your information needs to our report repository of Market research reports and guide you through your purchasing decision. We are based out of silicon valley of India (Bengaluru) and provide 24/7 online and offline support to all our customers and just a phone call away.

Contact Us:
Valuates Reports
sales@valuates.com
For U.S. Toll Free Call +1 (425) 388-2538
For IST Call +91-8040957137

To know more visit us on:

Website: https://reports.valuates.com/
Linkedin: www.linkedin.com/company/valuatesreports
Facebook: www.facebook.com/valuatesreports
Twitter: www.twitter.com/valuatesreports
Instagram: www.instagram.com/reportsvaluates
Youtube: www.youtube.com/channel/UCH4wNXynaTZbiD5m92WQI4A

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Prostate Cancer Diagnostics Market is valued at 10000 million US$ in 2018 and will reach 17600 million US$ by the end of 2025, growing at a CAGR of 7.3% | Valuates Reports here

News-ID: 1761478 • Views: 675

More Releases from Valuates Reports

Lawn and Garden Equipment Market Size, Share, Trends, Segmentation Analysis, For …
LAWN AND GARDEN EQUIPMENT MARKET SIZE The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section
Graphene Statistics | Industry Report, Market Demand, Size & Share, Forecast 202 …
Graphene Market Report by Type (Mono-layer & Bi-layer Graphene, Few Layer Graphene, Graphene Oxide, and Graphene Nano Platelets), and Application (RFID, Composites, Sensors, Research & Development, Energy storage, Functional ink, and Polymer additives, Tire, Coatings, and Others) The global graphene market size valued at $87.5 million in 2019, and is projected to reach $876.8 million by 2027, growing at a CAGR% of 40.2% from 2020 to 2027. Factors that are expected to
Digital Education Market Size, Forecast Growth, Segmentation Analysis, Share, In …
Market Analysis and Insights: Global Digital Education Market The global Digital Education market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-38Q4116/Global_Digital_Education With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Digital Education market to help players in achieving a
Smart Retail Market Report Analysis - Global Industry Size & Share, Growth, Tren …
The global Smart Retail market size was USD 12.410 Billion in 2019 and it is expected to reach USD 30.730 Billion by the end of 2026, with a CAGR of 13.7% during the forecast period 2020-2026. In today's retail market, traditional brick-and-mortar retailers are facing extreme competition from the rapidly expanding e-commerce sector. Therefore, to get back their customers, conventional retailers need to implement smart retail technologies. Technology help to strengthen

All 5 Releases


More Releases for Cancer

Primary Prevention of Cancer
Primary prevention of cancer aims to prevent the disease before it ever occurs. More than 4 in 10 cancers as well as cancer deaths are linked to modifiable risk factors that can be altered as part of primary cancer prevention. The modifiable risk factors for primary prevention include: 1. Cigarette smoking: Smoking causes almost all cases of lung cancer and accounts for 30% of all cancer deaths. Prevention strategy for this risk
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and
Natural Cancer Treatment
Cancer is going to be the number one killer in the world beginning from the year 2010! Facts of Cancer Cancer is a group of over 100 diseases that cause the cells in your body to grow to an uncontrollable level, as their normal growth regulating mechanism experiences an imbalance due to numerous external and internal factors. Many of the reasons for this scenario to occur are still unknown to medical science. However,